Evidence map›Paper›PMID 24574537›Full record

ArticleClinical and vaccine immunology : CVI2014

Chimeric plantibody passively protects mice against aerosolized ricin challenge.

Erin K Sully, Kevin J Whaley, Natasha Bohorova, Ognian Bohorov, Charles Goodman, Do H Kim, Michael H Pauly, Jesus Velasco, Ernie Hiatt, Josh Morton and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Erin K SullyDivision of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Kevin J Whaley
Natasha Bohorova
Ognian Bohorov
Charles Goodman
Do H Kim
Michael H Pauly
Jesus Velasco
Ernie Hiatt
Josh Morton
Kelsi Swope
Chad J Roy
Larry Zeitlin
Nicholas J Mantis
Mapp Biopharmaceutical (United States) · USOwensboro Health · USNew York State Department of Health · USTulane University · USUniversity at Albany, State University of New York · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
An Antibody Immunoprotectant for Category B ToxinsR01AI098774 · NIAID · MAPP BIOPHARMACEUTICAL, INC. · PI ZEITLIN, LARRY · 2012 to 2016
$6.2M
Training in Biodefense and Emerging Infectious DiseaseT32AI055429 · NIAID · WADSWORTH CENTER · PI MCDONOUGH, KATHLEEN A · 2004 to 2014
$2.2M
Development of a monoclonal immunoprotectant for ricinR43AI091078 · NIAID · MAPP BIOPHARMACEUTICAL, INC. · PI ZEITLIN, LARRY · 2010 to 2011
$600k
NIAID NIH HHS 5R43AI91078NIAID NIH HHS AI098774NIAID NIH HHS R01 AI098774NIAID NIH HHS R43 AI091078NIAID NIH HHS T32 AI055429NIH HHS OD-011104-51NIH HHS P51 OD011104
6 · The paper itself

Abstract

Recent incidents in the United States and abroad have heightened concerns about the use of ricin toxin as a bioterrorism agent. In this study, we produced, using a robust plant-based platform, four chimeric toxin-neutralizing monoclonal antibodies that were then evaluated for the ability to passively protect mice from a lethal-dose ricin challenge. The most effective antibody, c-PB10, was further evaluated in mice as a therapeutic following ricin exposure by injection and inhalation.

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, NeutralizingAntitoxinsFemaleImmunization, PassiveMice, Inbred BALB CPlantibodiesPoisoningRicinSurvival AnalysisTreatment OutcomeAntibodies, MonoclonalAntibodies, NeutralizingAntitoxinsPlantibodiesRicin

Identifiers

PMID24574537
PMCPMC4018890
OpenAlexW2137761002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.